Live
- Sri Lanka concludes sovereign bond restructuring
- Lal Krishna Advani hospitalised at Delhi's Apollo Hospital
- Modi performs puja at Triveni
- Jammu records season’s lowest minimum temperature as Kashmir valley shivers
- Scheme to give Rs 1K to women to be rolled out in 15 days
- Flirty Texts That Turn into Dates
- ‘Asli’ Sonakshi shares a glimpse of herself in ‘golden hour’
- Shraddha Kapoor took ‘thepla’ for her ‘foreign’ trip
- ChatGPT Now Supports Video Inputs: All Details
- B.Com vs BBA: Which degree better prepares you for an MBA?
ICMR plans to launch 1st indigenous vaccine for Covid-19 by August 15
The Indian council of Medical Research (ICMR) plans to launch indigenous vaccine for COVID-19 by August 15 after the completion of the clinical trials.
Hyderabad: The Indian council of Medical Research (ICMR) plans to launch indigenous vaccine for COVID-19 by August 15 after the completion of the clinical trials.
It has selected 13 institutions across the country for clinical trials and asked them to initiate subject enrollment by July 7.
ICMR Director General Balram Bhargava, in a letter to the heads of the selected institutions, informed them that it has partnered with Hyderabad-based Bharat Biotech International Limited (BBIL) to fast-track clinical trials of the indigenous COVID-19 vaccine (BBV152 COVID vaccine).
It noted that this is the first indigenous vaccine being developed by India and is one of the top priority projects which is being monitored at the topmost level of the government. "The vaccine is being derived from a strain of SARS-CoV-2 isolated by ICMR-National Institute of Virology, Pune. ICMR and BBIL are jointly working for the preclinical as well as clinical development of this vaccine," he wrote.
"It is envisaged to launch the vaccine for public health use latest by 15th August 2020 after completion of all clinical trials. BBIL is working expeditiously to meet the target, however the final outcome will depend on the cooperation of all clinical trial sites involved in this project," reads the letter dated July 2.
Informing the institutions of their selection as clinical trials sites for the vaccine, the IMCR director general strictly advised them to fast track all approvals related to initiation of the clinical trial and ensure that the subject enrollment is initiated no later July 7, 2020.
"Kindly note that non-compliance will be viewed very seriously. Therefore, you are advised to treat this project on highest priority and meet the given timelines without any lapse," he added.
The list of institutions involved in vaccine trials include Nizam's Institute of Medical Sciences (NIMS), Hyderabad, King George Hospital, Visakhapatnam, University of Health Sciences, Rohtak, All India Institute of Medical Sciences (AIIMS), New Delhi and AIIMS Patna.
